ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/27 | 1,638 | 1,668 | 1,637 | 1,668 | +47 | +2.9% | 311,100 |
| 2022/12/26 | 1,659 | 1,668 | 1,616 | 1,621 | -40 | -2.4% | 271,800 |
| 2022/12/23 | 1,665 | 1,671 | 1,641 | 1,661 | -20 | -1.2% | 290,300 |
| 2022/12/22 | 1,695 | 1,698 | 1,674 | 1,681 | -8 | -0.5% | 249,300 |
| 2022/12/21 | 1,695 | 1,707 | 1,672 | 1,689 | -18 | -1.1% | 312,100 |
| 2022/12/20 | 1,776 | 1,780 | 1,693 | 1,707 | -71 | -4% | 355,700 |
| 2022/12/19 | 1,791 | 1,797 | 1,770 | 1,778 | -23 | -1.3% | 265,400 |
| 2022/12/16 | 1,805 | 1,812 | 1,787 | 1,801 | -29 | -1.6% | 385,300 |
| 2022/12/15 | 1,875 | 1,883 | 1,829 | 1,830 | -50 | -2.7% | 300,000 |
| 2022/12/14 | 1,857 | 1,904 | 1,850 | 1,880 | +39 | +2.1% | 406,000 |
| 2022/12/13 | 1,885 | 1,898 | 1,834 | 1,841 | -44 | -2.3% | 396,600 |
| 2022/12/12 | 1,878 | 1,915 | 1,868 | 1,885 | +7 | +0.4% | 232,700 |
| 2022/12/09 | 1,864 | 1,888 | 1,864 | 1,878 | +3 | +0.2% | 372,300 |
| 2022/12/08 | 1,892 | 1,896 | 1,844 | 1,875 | -14 | -0.7% | 243,800 |
| 2022/12/07 | 1,864 | 1,900 | 1,858 | 1,889 | +4 | +0.2% | 224,900 |
| 2022/12/06 | 1,880 | 1,905 | 1,880 | 1,885 | -4 | -0.2% | 238,300 |
| 2022/12/05 | 1,885 | 1,889 | 1,857 | 1,889 | +19 | +1% | 233,300 |
| 2022/12/02 | 1,900 | 1,900 | 1,866 | 1,870 | -49 | -2.6% | 332,900 |
| 2022/12/01 | 1,959 | 1,959 | 1,904 | 1,919 | +7 | +0.4% | 232,100 |
| 2022/11/30 | 1,890 | 1,919 | 1,875 | 1,912 | -8 | -0.4% | 301,000 |
| 2022/11/29 | 1,941 | 1,941 | 1,905 | 1,920 | -36 | -1.8% | 225,300 |
| 2022/11/28 | 2,000 | 2,000 | 1,938 | 1,956 | -31 | -1.6% | 261,300 |
| 2022/11/25 | 1,988 | 2,008 | 1,971 | 1,987 | +5 | +0.3% | 321,200 |
| 2022/11/24 | 1,978 | 1,991 | 1,968 | 1,982 | +22 | +1.1% | 395,700 |
| 2022/11/22 | 1,951 | 1,993 | 1,950 | 1,960 | +5 | +0.3% | 322,000 |
| 2022/11/21 | 1,957 | 1,967 | 1,947 | 1,955 | -2 | -0.1% | 270,200 |
| 2022/11/18 | 1,959 | 1,981 | 1,952 | 1,957 | -1 | -0.1% | 230,500 |
| 2022/11/17 | 1,955 | 1,990 | 1,951 | 1,958 | +4 | +0.2% | 157,200 |
| 2022/11/16 | 1,983 | 1,983 | 1,937 | 1,954 | -31 | -1.6% | 218,400 |
| 2022/11/15 | 2,000 | 2,008 | 1,958 | 1,985 | -8 | -0.4% | 439,800 |
| 2022/11/14 | 1,907 | 2,009 | 1,899 | 1,993 | +97 | +5.1% | 607,600 |
| 2022/11/11 | 1,899 | 1,917 | 1,870 | 1,896 | +41 | +2.2% | 481,700 |
| 2022/11/10 | 1,831 | 1,878 | 1,820 | 1,855 | +7 | +0.4% | 331,500 |
| 2022/11/09 | 1,870 | 1,887 | 1,844 | 1,848 | -29 | -1.5% | 352,700 |
| 2022/11/08 | 1,912 | 1,925 | 1,871 | 1,877 | -17 | -0.9% | 424,300 |
| 2022/11/07 | 1,920 | 1,921 | 1,876 | 1,894 | -34 | -1.8% | 454,100 |
| 2022/11/04 | 2,006 | 2,011 | 1,924 | 1,928 | -102 | -5% | 579,000 |
| 2022/11/02 | 2,065 | 2,078 | 2,030 | 2,030 | -67 | -3.2% | 473,700 |
| 2022/11/01 | 2,230 | 2,239 | 2,095 | 2,097 | -118 | -5.3% | 554,400 |
| 2022/10/31 | 2,181 | 2,246 | 2,154 | 2,215 | +54 | +2.5% | 646,800 |
| 2022/10/28 | 2,092 | 2,193 | 2,088 | 2,161 | +36 | +1.7% | 989,600 |
| 2022/10/27 | 2,190 | 2,226 | 2,093 | 2,125 | +78 | +3.8% | 1,375,900 |
| 2022/10/26 | 1,984 | 2,065 | 1,979 | 2,047 | +111 | +5.7% | 613,000 |
| 2022/10/25 | 1,981 | 1,986 | 1,932 | 1,936 | -34 | -1.7% | 390,600 |
| 2022/10/24 | 2,005 | 2,018 | 1,965 | 1,970 | -13 | -0.7% | 327,900 |
| 2022/10/21 | 1,990 | 2,015 | 1,972 | 1,983 | -15 | -0.8% | 396,600 |
| 2022/10/20 | 2,048 | 2,074 | 1,995 | 1,998 | -60 | -2.9% | 430,900 |
| 2022/10/19 | 2,080 | 2,088 | 2,022 | 2,058 | -17 | -0.8% | 922,900 |
| 2022/10/18 | 2,099 | 2,106 | 2,051 | 2,075 | +11 | +0.5% | 330,500 |
| 2022/10/17 | 2,076 | 2,086 | 2,037 | 2,064 | -55 | -2.6% | 338,000 |
651～
700
件表示中 / 7022件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 95,000円 | +20.3% | - | 0.00% | 168.44倍 | 1.31倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ハートシード | 364,000円 | +246.7% | - | 0.00% | 774.47倍 | 11.02倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| あすかＨＤ | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
